4-Quinolinecarboxylic acid (CAS 486-74-8)
4-Quinolinecarboxylic acid
CAS 486-74-8 · C10H7NO2 · MW 173.17 g/mol
Chargement de la molécule...
Littérature scientifique
Related literature
20 artykułów · 7 open access · Źródła: PubMed, OpenAlex, Semantic Scholar
📈 Timeline publikacji (20 artykułów)
Wysokość słupka = liczba artykułów w roku. Hover dla szczegółów.
et al. (1985)
et al. (2006)
Zakira Naureen, Najeeb Ur Rehman, Hidayat Hussain et al. (2017) · Frontiers in Microbiology
et al. (2024)
Yu. A. Zhuravleva, A. V. Zimichev, M. Zemtsova et al. (2008)
H. Hayashi, Y. Miwa, S. Ichikawa et al. (1993) · Journal of Medicinal Chemistry
AI Summary
Compound 6f dose-dependently attenuated both the incidence and frequency of emetic episodes induced by cisplatin in the dog more potently than ondansetron and is now under further investigation as a drug for treating gastrointestinal disorder.
Compound 6f dose-dependently attenuated both the incidence and frequency of emetic episodes induced by cisplatin in the dog more potently than ondansetron and is now under further investigation as a drug for treating gastrointestinal disorder.
N. Jaekel, Susann Schulze, Christina Zahn et al. (2025) · Blood
AI Summary
Safety of FED in combination with CC-486 and week 24 response were key primary objectives of the phase I and II respectively, and FED an approved MF therapy was evaluated in a clinical trial.
Safety of FED in combination with CC-486 and week 24 response were key primary objectives of the phase I and II respectively, and FED an approved MF therapy was evaluated in a clinical trial.
(2008) · Organic Syntheses
N. Hakobyan, A. Grigoryan, R. Madoyan et al. (2026) · Russian journal of bioorganic chemistry
AI Summary
The Atophan scaffold is a valuable basis for designing multitarget bioactive molecules and promising lead compounds for further development as antidepressants, antibacterial, antifungal, and anticancer agents are confirmed.
The Atophan scaffold is a valuable basis for designing multitarget bioactive molecules and promising lead compounds for further development as antidepressants, antibacterial, antifungal, and anticancer agents are confirmed.
$ PaywallDOI ↗
Shakir Ullah, Nosheen Malak, Afshan Khan et al. (2025) · Scientific Reports
M. Cygler, C. P. Huber (1985)
SHIZUO KADOYA, SENKICHI NAGASAKI (1979) · YAKUGAKU ZASSHI
A. Musumeci (1981) · Inorganica Chimica Acta
(2015)
A. Palomer, L. Anglada (2010)
$ Paywall
アロマタリオ ヴァレンティーナ, トゥルチェッタ ステファノ, マッサルド ピエトロ (2004)
$ Paywall
J. Liu, Y. Wei, H. Guo (2001) · Yao xue xue bao = Acta pharmaceutica Sinica
AI Summary
In vitro antibacterial activities of the compounds (8-15) against Staphylococcus aureus, Escherichia coli-26 and Pseudomonas aeruginosa-17 were lower than control of ciprofloxacin.
In vitro antibacterial activities of the compounds (8-15) against Staphylococcus aureus, Escherichia coli-26 and Pseudomonas aeruginosa-17 were lower than control of ciprofloxacin.
$ PaywallPubMed ↗
J. Qi, Hui-yuan Guo, Ming-liang Liu et al. (2004) · Yao xue xue bao = Acta pharmaceutica Sinica
AI Summary
Compounds (23, 24 and 26) showed excellent antibacterial activity in vitro and in vivo and should be worth further investigation.
Compounds (23, 24 and 26) showed excellent antibacterial activity in vitro and in vivo and should be worth further investigation.
L. Kononov, G. Veinberg, É. Liepin'sh et al. (1988)
K.P. Madauss, S.P. Williams, D.N. Deaton (2010) · Worldwide Protein Data Bank
$ PaywallDOI ↗
Dane z PubMed (NIH NLM), OpenAlex (CC0), Semantic Scholar (AI2). AI Summary wygenerowane przez Semantic Scholar TLDR. Artykuły z ikoną 
wymagają płatnego dostępu.